Wordt geladen...
How I treat newly diagnosed chronic phase CML
The progress made in the understanding of chronic myeloid leukemia (CML) since the recognition of a common chromosomal abnormality to the introduction of ever more effective tyrosine kinase inhibitors is unprecedented in cancer. The expected survival for patients diagnosed with CML today, if properl...
Bewaard in:
| Gepubliceerd in: | Blood |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4916560/ https://ncbi.nlm.nih.gov/pubmed/22613793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-378919 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|